Mucinous Adenocarcinoma
7 clinical trials · Condition
◉ Watch Mucinous Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei (NCT03976973) | Mucpharm Pty Ltd | 2022-05-01 |
| Phase I Trial HIPEC With Nal-irinotecan (NCT04088786) | Stony Brook University | 2019-10-22 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00565851) | National Cancer Institute (NCI) | 2007-12-06 |
Track Mucinous Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.